Previously, p53, a nuclear transcription factor controlling proliferation and genetic stabilization, was a prime candidate and was the most prominent change seen in a large number of cancers, but very early on, a lack of correlation between p53 expression and tumor stage suggested that p53 protein overexpression is an early event in these tumors [22]. This evidence concerns the gene TP53 and cancer.